In the course of a new and groundbreaking study, led by Dr, Natalia Freund and the doctoral candidate Avia Waston at the Sackler Medical Faculty, the research group succeeded in isolating monoclonal antibodies, which hindered the growth of tuberculosis germs in laboratory mice.
COVID-19 can spread from asymptomatic but infected people through small aerosol droplets in their exhaled breath. Most studies of the flow of exhaled air have focused on coughing or sneezing; however, speaking while near one another is also risky. In Physics of Fluids, scientists used smoke and laser light to study the flow of expelled breath near and around two people conversing in various relative postures commonly found in the service industry, such as in hair salons, medical exam rooms, or long-term care facilities.
Research from Queen’s University Belfast suggests that largescale antibody testing could lower social activity and thus contagion of COVID-19 (Coronavirus).
ROCKVILLE, MD – A tenth of all intensive care unit patients worldwide, and many critical patients with COVID-19, have acute respiratory distress syndrome (ARDS).
There is now keen interest in deeper investigation of infectious agents as the trigger of Alzheimer's disease
People with COVID-19 may lose their sense of smell and taste for up to five months after infection, according to a preliminary study released today, February 22, 2021, that will be presented at the American Academy of Neurology’s 73rd Annual Meeting being held virtually April 17 to 22, 2021.
روتشستر، ولاية مينيسوتا: إن المرضى المصابين بفيروس الكورونا المستجد (كوفيد-19) عرضة لمجموعة من المضاعفات العصبية التي تشتمل على التهاب الدماغ.
Los pacientes con COVID-19 corren riesgo de presentar complicaciones neurológicas, incluida una encefalitis o inflamación del cerebro.
Around 80% of the UK population is currently infected with human cytomegalovirus (HCMV) and in developing countries this can be as high as 95%.
University Hospitals in Cleveland to be a clinical research site of a trial evaluating investigational drug RHB-107, also know as Upamostat, for COVID-19 in patients who do not require hospitalization.
A team of researchers at Beth Israel Deaconess Medical Center (BIDMC) has developed a mathematical means of assessing tests’ false-negative rate.
A new study by an international team of researchers found that adults with Down syndrome are more likely to die from COVID-19 than the general population, supporting the need to prioritize vaccinating people with the genetic disorder.
Patients with COVID-19 are at risk for neurologic complications, including encephalitis, or inflammation of the brain. "Encephalitis cases have been reported in patients with COVID-19, although on the whole it appears to be a relatively rare complication," says Michel Toledano, M.D., a Mayo Clinic neurologist. In the case of encephalitis caused by communicable diseases for which there is a vaccine available, getting vaccinated is the best way of preventing the disease.
The course and severity of COVID-19 in individual patients is largely influenced by the interaction between the SARS-CoV-2 coronavirus and the human immune system.
Fool the novel coronavirus once and it can’t cause infection of cells, new research suggests. Scientists have developed protein fragments that bind to the Spike protein, effectively tricking the virus into “shaking hands” with a replica rather than the receptor that lets the virus into a cell.
In a study published in Open Forum Infectious Diseases, researchers at Children’s Hospital of Philadelphia (CHOP) describe the array of rashes seen in MIS-C patients at their hospital through late July 2020, providing photos and information that could help doctors diagnose future cases.
ROCKVILLE, MD – Coronaviruses exploit our cells so they can make copies of themselves inside us.
April 2021 highlights from AJPH Issue includes COVID-19-related articles around deaths linked to unemployment, higher than reported death toll in Florida and crowdfunding campaigns spreading misinformation
The approval of COVID-19 vaccines has brought with it hope, excitement, as well as concerns. AARDA is committed to ensuring you have the information you need to make the right decisions for your health. A panel of medical experts will discuss frequently asked questions regarding COVID-19 vaccines, as well as address audience questions during our upcoming Autoimmune Newscast, “Should I Get the COVID-19 Vaccine?” on 2/26 at 2pm ET
RSS
Medicine keyboard_arrow_right
Sciencekeyboard_arrow_right
Life keyboard_arrow_right
Business keyboard_arrow_right
Journal News keyboard_arrow_right
By Location keyboard_arrow_right
Meetings, Grants, and Events keyboard_arrow_right